Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer

Introduction: In 1994, we started carbon-ion radiotherapy (CIRT) for peripheral stage I non-small-cell lung cancer (NSCLC). First, two phase I/II clinical trials demonstrated the optimal doses of 90.0 GyE in 18 fractions over 6 weeks (Protocol 9303) and 72.0 GyE in 9 fractions over 3 weeks (Protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Wataru, Nakajima, Mio, Yamamoto, Naoyoshi, Tsuji, Hiroshi, Kamada, Tadashi, Tsujii, Hirohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Oral Session 05: Clinical Results of Ion Beam Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941516/
http://dx.doi.org/10.1093/jrr/rrt216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941516/
http://dx.doi.org/10.1093/jrr/rrt216

Ejemplares similares